IMRX stock

Immuneering Corp (IMRX) financials · $124.2M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Immuneering Corp (IMRX) $124.2M cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$59.4M-$64.1M
Net Income-$56.0M-$61.0M
EPS (Diluted)-$1.27-$2.04
Cached annual balance sheet
LineFY2025FY2024
Total Assets$232.0M$52.7M
Current Assets$176.2M$39.6M
Cash & Equivalents$128.6M$36.1M
PP&E$938.5K$1.12M
Total Liabilities$13.5M$11.3M
Current Liabilities$10.1M$7.50M
Shareholders' Equity$218.5M$41.4M
Retained Earnings-$280.3M-$224.3M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$45.3M-$55.0M
CapEx$142.2K$84.9K
Investing Cash Flow-$88.7M$26.4M
Financing Cash Flow$226.6M$5.30M
Net Change in Cash$92.5M-$23.3M
Free Cash Flow-$45.5M-$55.1M
These statements as JSON? API free 100/day

FAQ

What is IMRX P/E and revenue?

Immuneering Corp (IMRX) $124.2M cap.

What is IMRX revenue?

IMRX income-statement cache has no revenue figure yet.

Is IMRX profitable?

Immuneering Corp last cached net income is -$56.0M (FY2025).

What are IMRX total assets?

Immuneering Corp last cached total assets are $232.0M (FY2025).

What is IMRX free cash flow?

Immuneering Corp last cached free cash flow is -$45.5M (FY2025).

Not investment advice. Cached statements, not a live tape.